Prophylactic Immunomodulatory (IM) Therapy

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSHNCT02716246RAREPhase 2, Phase 3Recruiting2029-03Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.